[Clinical and hormonal evaluation of the corticotropic effect of delayed-action beta 1-24 tetracosapeptide].
D015068:17-Ketosteroids / Q000652:urine; D000172:Acromegaly / Q000188:drug therapy*; D000310:Adrenal Gland Neoplasms / Q000188:drug therapy*; D000311:Adrenal Glands / Q000187:drug effects; D000324:Adrenocorticotropic Hormone / Q000008:administration & dosage*; D000328:Adult; D003692:Delayed-Action Preparations; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010455:Peptides / Q000008:administration & dosage*
D015068:17-Ketosteroids; D003692:Delayed-Action Preparations; D010455:Peptides; D000324:Adrenocorticotropic Hormone
Valutazione clinico-ormonale dell'azione corticotropa svolta dal tetracosapeptide beta 1-24 ad azione prolungata.